June 2021
Congratulations to Professor Melissa Southey, who received an OAM of the Order of Australia in this month’s Queen’s Birthday Honours roll, for her service to epidemiology and precision medicine. Professor Southey is Research Director, MPCCC; Chair of Precision Medicine, School of Clinical Sciences, Monash University and Director of Biobanking Victoria, Monash University.

BroSupPORT: helping men living with prostate cancer to share and compare

The Prostate Cancer Outcomes Registry – Victoria (PCOR-Vic) at Monash University’s School of Public Health and Preventive Medicine, has been working with survivors of prostate cancer to  co-design a new online support portal for Victorian men living with the disease.

Continue reading »

New fertility treatment provides options for metastatic testicular cancer patients

A technique new to Monash Health can help males with metastatic testicular cancer and provide new hope for male fertility.   

A minority of men with testicular cancer can experience sperm production issues and have no detectable sperm in their ejaculate.

Continue reading »

A world first in imaging technology

Magnetic Particle Imaging (MPI) is a new non-invasive molecular imaging technique that offers significantly increased tracer sensitivity over MRI and remarkably faster acquisition times than nuclear medicine, opening the door to cutting edge opportunities for interdisciplinary projects in medical research, chemistry and biotechnology.

Continue reading » 

Monash researchers make fundamental advance in understanding T cell immunity

Monash University researchers have provided a fundamental advance regarding how T cells become activated when encountering pathogens such as viruses.

Continue reading » 

HPV vaccine shows success in gay, bisexual men

A study by Monash University and Alfred Health found a 70 per cent reduction in one type of human papillomavirus (HPV) in gay and bisexual men after the implementation of the school-based HPV vaccination program.

Continue reading » 

Cancer care at home a lifesaver for Patricia

It was April last year, and Melbourne was in lockdown chaos. But Patricia McCabe had a much more personal crisis happening – she’d just found a lump under her arm, and it was breast cancer.

Continue reading » 

Dromana tattooist Erin Liversidge waging a cancer fight she never saw coming

Erin Liversidge learnt she had breast cancer on Christmas eve last year at the age of 33 after a routine night feed of her youngest daughter uncovered an unusual lump.

Continue reading » 

Alice Urban

Alice Urban, Manager of Allied Health and Aboriginal Health, Community Care, at Peninsula Health started her career in aged care and community aged psychiatry.
Her current roles include Community Health and Aboriginal Health support.

Continue reading » 

Latest COVID-19 Resources

The Medical Oncology Group of Australia this week released its position statement on COVID19 vaccination for patients with solid tumours

Visit the Victorian Government’s website for Victorian health service guidance and response to COVID19 risks

The Victorian COVID-19 Cancer Taskforce has launched the Got Cancer? Get Vaccinated social media campaign to communicate clear, very direct, evidence-based messages that provide both assurance and motivation to people with cancer about the safety, risks and benefits of the COVID19 vaccine. Help us to share the message and urge patients with cancer to get vaccinated.  Materials include a printable A4 poster for use in clinical areas.

Cancer Council Victoria’s information and support line

Patients and carers can access expert advice from trained cancer nurses by contacting Cancer Council Victoria on 13 11 20 or by submitting the new online referral form.

Palliative Care Advice Service

The Palliative Care Advice Service (PCAS) is a free, confidential service available to all Victorian’s seeking information about life limiting illness, palliative or end of life care.

For healthcare workers, nurses and doctors PCAS offers guidance about prescribing, symptom management, locating appropriate services and decision-making. The Palliative Care Advice Service is available 7am-10pm, seven days a week. Call 1800 360 000 or visit for further information.

National Cancer Screening Registry – Healthcare Provider portal

Cancer Australia this month launched the Healthcare Provider Portal, a self-service alternative for health professionals to access and submit bowel and cervical screening data electronically in the National Cancer Screening Register.

For further information on how to access the national register click here.

The Survivorship Diary

The Survivorship Diary is a free resource that has been designed to assist people diagnosed with a brain tumour, or brain cancer, to keep track of their appointments, medications and important questions to ask specialists.

The diary has chapters on diagnosis, surgery, radiation, chemotherapy, neurology, emotional wellbeing, living with brain cancer, financial and insurance considerations, palliative care,
The Peace of Mind Foundation are distributing these diaries, which have been created by Cassandra Bennett, who has herself been diagnosed with brain cancer.Find out more about the Survivorship Diary.

Find out more about the Survivorship Diary

Expansion of

The Australian Cancer Survivorship Centre ACSC has announced that is expanding to add three cancer types to benefit more patients and cancer survivors. Visit the website for a free online survivorship care plan generator for cancer survivors of early‐stage breast, bowel and prostate cancers.

Survivorship care plans generally include a summary of a person’s cancer diagnosis and treatment, plans for follow‐up, information about strategies to remain well and resources. They also support transition from the treatment to the post‐treatment phase, providing a flexible communication tool for cancer survivors and health professionals to improve the delivery of care.

Cancer screening rates decreased last year, let's change that

During the COVID-19 pandemic, Victoria saw a 32% decrease in mammograms ordered in 2020, compared to the year prior.

The number of cervical cancer tests fell in April 2020 when the first wave of the COVID-19 pandemic occurred. In August 2020, a marked decrease in the number of cervical cancer tests was evident in Victoria, potentially an effect of the state’s second wave of COVID-19 cases.

Cancer screening is essential to increasing positive health outcomes.

Below we have collated more information on cancer screening resources.

Thermo Fisher Scientific Oncomine Clinical Research Grant program – NOW OPEN

GRANT SUBMISSION DATES: Submissions are open from June 14 to July 16, 2021.

TOPICS OF CALL: Immuno-Oncology

Apply for a grant of up to USD $200,000.

Proposals will be considered based on scientific merit as evaluated by independent and internationally recognised experts.

To apply, complete the grant proposal form attached and submit grant proposal HERE. For more information, including an overview, grant details, selection process and more, please click here:

Code of Conduct for Evaluators
Grant Guidelines
Grant Official Rules
Privacy Policy

Please note, there is an error in the Grant Official Rules document (Pg 2), which may come across as though groups from Australia are ineligible to apply. This is not the case. All ANZ researchers are absolutely eligible to apply for the grant! 

2021 Victorian Cancer Agency Funding Round - now open

The Victorian Cancer Agency’s research grants have been supporting innovation and excellence in cancer research since 2006, investing more than $250 million into translational research and infrastructure.

The following funding schemes are now open and will close at 2.00 pm AEST on Monday 13 September 2021:

Early Career Research Fellowships
  • Biomedical research stream
  • Non-biomedical research stream

Mid-Career Research Fellowships

  • Biomedical research stream
  • Non-biomedical research stream

Quality and Safety in Cancer Care Research Grants

  • Limited to research projects in medical oncology, malignant haematology, radiation oncology and cancer surgery intended to improve cancer survival outcomes.

More information, including guidelines, funding rules and a link to the application forms can be found at:

MRFF 2021 Rare Cancers Rare Diseases Unmet Need General – Grant Opportunity

Applications via NHMRC
Closing Dates:
Stream 2: 5.00pm Wednesday 7 July 2021
Streams 1, 3, 5, 6 and 7: 5.00pm Wednesday 18August 2021 
Please note there are 7 specific streams in this round of RCRDUN and min data dates vary across streams

Min Data
Stream 2: 5.00pm on Wednesday 23 June 2021
Streams 1, 3, 4, 5, 6 and 7: 5.00pm on Wednesday 4 August 2021
Grants are a max of $5M, $10M or $15M depending on Stream.
Funding over 3 years. See guidelines for details

A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity (i.e. a person may be named as a Chief Investigator on a maximum of one application per Stream).

MRFF – 2021 COVID 19 Health Impacts and Vaccination Schedules Grant Opportunity

Applications via NHMRC

Closing Date: 5.00pm Wednesday 18 August 2021 
Min Data 5.00pm Wednesday 4 August 2021 
Grants are a max of $15M
Funding over 3 years. See guidelines for details

Stream 1: study individuals that have tested positive for COVID-19 to improve understanding of the long term health impacts of COVID-19

Stream 2: conduct clinical trials to generate evidence on how individuals or populations with immunocompromising conditions respond to COVID-19 vaccination, to inform vaccine schedules

Stream 3: conduct clinical trials to generate knowledge on the efficacy of vaccine schedules that combine different COVID-19 vaccines.

A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity.

Cancer Trials Management Scheme Competitive Grants

Together, Cancer Council Victoria and the Victorian Cancer Agency will fund three $500K projects for a maximum of 3 years.
This funding will be offered to projects that address:
  • an unmet need and
  • build capacity to conduct and recruit to cancer clinical trials in supportive care and/or survivorship. 
Click here for grant guidelines and to apply. For further information contact Dorani Lacey at Cancer Council Victoria on 03 9514 6319 or email
Applications will close on Thursday 15 July 2021.

Cancer Australia Priority-driven collaborative cancer research – for funding commencing in 2022

PdCCRS applications will only be accepted if an application has been submitted to NHMRC’s Ideas Grants or Clinical Trials and Cohort Studies Grants schemes and a corresponding PdCCRS Questions application form has been submitted to Cancer Australia. For more information contact

Applications close 1 September 2021

Practical solutions for frontline clinical problems

Applications for the 2021 round of Monash Institute of Medical Engineering (MIME) Seed Funding are now open! Apply HERE.

Seed funding is available to support partnerships with IT/digital health, engineering or design researchers to discover new medical solutions including technologies, devices and digital health.

Applications may request up to $50,000 per project with cardiac and big data themed proposals to be highly regarded.

Successful past applicants are invited to apply for top up funding. Previously unsuccessful applications can also be resubmitted for consideration.

Phase 1 applications are now open until Friday 23 July. Selected proposals will then be announced on the MIME website on Monday 2 August. 

Questions? Contact Andrew Carey, MIME Program Manager on phone 0408 700 029 or email

2021 GSK Award for Research Excellence: Nominations Now Open

The GSK Award for Research Excellence (ARE) is one of the most prestigious and longstanding awards available to the Australian medical research community. Since 1980, the annual GSK ARE has been awarded to individuals or two-person teams with very significant existing track records who are well placed to further their contributions in the near future. A financial grant of $80,000 to the winner(s)’ institution supports this goal.

To nominate someone, complete the 2021 ARE Nomination Form. For further information about the nominations process view the Terms of Reference. Please direct queries regarding the award to

Nominations close at midnight on Friday 30 July 2021. The award will be presented at the Research Australia Awards Night, Thursday 9 December 2021 in Sydney.

Find out more  »

Participate in research. SerOzNET: Studying the COVID-19 vaccine in Monash patients with cancer

Patients with cancer are eligible and recommended to receive the COVID-19 vaccination. Monash researchers on behalf of Cancer Australia are studying how well the COVID-19 vaccine works in patients with cancer, and what the side effects are. Find out more here or contact:  or 0428 803 521

BroSupPORT. Help improve prostate cancer support

Would you like to help design a supportive care website to support the needs of men after prostate cancer treatment, without leaving home?

Find out more »

Dry July

Dry July encourages you to go alcohol-free in July to raise funds for people affected by cancer. Funds raised will provide invaluable services for cancer patients, their families and carers.

Find out more »

Co-operative Research Centres Association Collaborate Innovate
When: 9 - 11 August
Where: Canberra
More information/Register 
COSA 48th Annual Scientific Meeting: Cancer care and research
When: 16 - 18 November
Where: Melbourne
More information


The Myeloma Landscape in Australia and New Zealand: The First 8 Years of the Myeloma and Related Diseases Registry (MRDR) Read article »

Predictors of real-world utilisation of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer Read article »

Risk factors for invasive fungal infection in 5-azacytidine treated patients with acute myeloid leukemia and myelodysplastic syndrome Read article »

Preoperative anaemia and thrombocytopenia are associated with venous thromboembolism complications after colorectal resection Read article »

Diagnostic tools used for melanoma: A survey of Australian general practitioners and dermatologists Read article »

Cancer clinical trial vs real-world outcomes for standard of care first-line treatment in the advanced disease setting Read article »

Pilot study of a combined genomic and epidemiologic surveillance program for hospital-acquired multidrug-resistant pathogens across multiple hospital networks in Australia Read article »

Australian Cancer Plan

Cancer Australia is to develop the first Australian Cancer Plan to provide an overarching national approach to cancer control that meets the needs of all Australians now and in the future.

Continue reading »
‘Devastated and sad’ after 36 years of research — early detection of ovarian cancer doesn’t save lives

My colleagues’ and my efforts to develop a screening test for the early detection of ovarian cancer capable of saving lives arrived at a sad moment last week. The final trial results of the research I’ve focused on for 36 years, published in The Lancet, found early ovarian cancer detection doesn’t save lives.

Continue reading »
Monash Partners Comprehensive Cancer Consortium (MPCCC) is a strategic alliance of health service and research organisations working in partnership to improve cancer outcomes through integrated, collaborative and innovative research, service improvement and clinical care programs. We are a consortium made up of clinical, research and allied partner organisations. 
Clinical partners
Alfred Health; Monash Health; Eastern Health; Peninsula Health; 
Cabrini Health; Epworth HealthCare

Research partners
Monash University; Hudson Institute of Medical Research

Allied partners
Southern Melbourne Integrated Cancer Service (SMICS); 
Monash Partners Academic Health Science Centre (Monash Partners).
If you would like to contribute to the MPCCC e-Newsletter email
Copyright © 2021 MPCCC, All rights reserved.